Mingfei Shi
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 detection and testing
-
- Curcumin's Biomedical Applications
Papers in
-
- SARS-CoV-2 and COVID-19 Research 2
-
- Advanced Drug Delivery Systems 2
- Advancements in Transdermal Drug Delivery 2
- Co-authors
- Ning Li (7 shared papers)Ruodan Xu (7 shared papers)Ping Song (4 shared papers)Jing Li (1 shared paper)Ziyun Li (3 shared papers)Guiying Dong (1 shared paper)Wei Guo (1 shared paper)Yongfeng Pang (1 shared paper)
In The Last Decade
Mingfei Shi
16 papers receiving 381 citations
Peers
Comparison fields: 5 of 81
- Infectious Diseases 140
- Molecular Medicine 26
- Endocrinology, Diabetes and Metabolism 72
- Pharmaceutical Science 29
- Complementary and alternative medicine 18
Countries citing papers authored by Mingfei Shi
This map shows the geographic impact of Mingfei Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfei Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfei Shi more than expected).
Fields of papers citing papers by Mingfei Shi
This network shows the impact of papers produced by Mingfei Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfei Shi. The network helps show where Mingfei Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingfei Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 128 | |
| 2 | 2020 | 85 | |
| 3 | 2020 | 42 | |
| 4 | 2022 | 34 | |
| 5 | 2023 | 19 | |
| 6 | 2021 | 18 | |
| 7 | 2021 | 18 | |
| 8 | 2020 | 14 | |
| 9 | [An analysis of health literacy about diabetes prevention and control and its influencing factors among the residents in six provinces in China]. | 2014 | 9 |
| 10 | [The study of diabetes-related behavior status and affecting factors among urban and suburban residents in six provinces in China]. | 2014 | 5 |
| 11 | 2021 | 4 | |
| 12 | 2023 | 3 | |
| 13 | 2024 | 2 | |
| 14 | 2025 | 1 | |
| 15 | 2025 | 1 | |
| 16 | [A study on risk factors and perceptions of diabetes among urban and suburban residents from six provinces in China]. | 2014 | 1 |
About Mingfei Shi
Mingfei Shi is a scholar working on Infectious Diseases, Pharmaceutical Science, Epidemiology, Complementary and alternative medicine and Immunology, having authored 16 papers that have together received 384 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (2 papers), Andrographolide Research and Applications (2 papers), Advancements in Transdermal Drug Delivery (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Pharmacological Effects of Natural Compounds (1 paper), Medicinal Plant Research (1 paper), Mycobacterium research and diagnosis (1 paper) and Transcranial Magnetic Stimulation Studies (1 paper). The work is most often cited by research in Infectious Diseases (140 citations), Molecular Medicine (26 citations), Endocrinology, Diabetes and Metabolism (72 citations), Pharmaceutical Science (29 citations) and Complementary and alternative medicine (18 citations). Mingfei Shi has collaborated with scholars based in China, Denmark and Vietnam. Frequent co-authors include Ning Li, Ruodan Xu, Ping Song, Jing Li, Ziyun Li, Guiying Dong, Wei Guo, Yongfeng Pang, Weibo Gao and Xianghai Zhou. Their work appears in journals such as Frontiers in Bioengineering and Biotechnology, Nano Today, Pharmaceutics, Scientific Reports and Phytomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.